Stay updated on Risankizumab in Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.

Latest updates to the Risankizumab in Psoriatic Arthritis Clinical Trial page
- CheckyesterdayChange DetectedA new revision label with v3.5.5 has been added to the page, signaling an updated document version without changing the substantive content.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe Related Info section, the AbbVie sponsor block, and the Helpful Links Provided by footer were removed. This reduces sponsor attribution and auxiliary links from the page while preserving the main study details.SummaryDifference0.1%

- Check23 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, signaling a newer version of the page's documentation for the study record (likely updates to linked documents or notices, not changes to study results).SummaryDifference0.0%

- Check37 days agoChange DetectedThe Study Documents section shows Revision: v3.5.3, replacing Revision: v3.5.2. This indicates an updated version of the documents provided by AbbVie.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0; no visible changes to the study details or page features.SummaryDifference0.0%

Stay in the know with updates to Risankizumab in Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.